Search
for
Sort by
Research 241–270 of 906
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Hair for the Long Haul: Alopecia Areata Cases and Considerations
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- Amla: An ancient medicinal plant with wide-ranging properties
- Practical Approach for Treatment lines of Alopecia Areata: Review Article
- Anatomy and Physiology of the Skin
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Dermatological adverse events with taxane chemotherapy
- Alopecia Areata Update
- Diagnosis of hyperandrogenism: Biochemical criteria
- Long-Term Epilation Using the EpiLight Broad Band, Intense Pulsed Light Hair Removal System
- Primary cicatricial alopecia
- Types of Hair Loss and Treatment Options, Including the Novel Low-Level Light Therapy and Its Proposed Mechanism
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Treatment options for alopecia: an update, looking to the future
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Hair Biology
- Frontal Fibrosing Alopecia: To Treat or Not to Treat?
- New drugs under investigation for the treatment of alopecias
- Hair Transplantation Update
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Androgen receptors are only present in mesenchyme-derived dermal papilla cells of red deer (Cervus elaphus) neck follicles when raised androgens induce a mane in the breeding season
- Frontal fibrosing alopecia: a case series of 65 patients seen in a single Italian centre
- An Update on Drug-Induced Pigmentation
- A regulatory perspective on pharmacokinetic/pharmacodynamic modelling
- Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG)*
- Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial
- Androgenetic, Diffuse and Senescent Alopecia in Men: Practical Evaluation and Management
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics